Journal · Updated 2026-08-11
How to Read a Compounded GLP-1 Label: The Seven Fields That Prevent the Serious Errors
By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify
The short answer
Seven fields, checked in order, before the first draw. Drug name — semaglutide or tirzepatide, matching what was prescribed. Concentration — the milligrams-per-milliliter figure that all syringe math runs through; this is the field whose misreading produces the overdose reports in our units guide, and it varies between pharmacies and batches, so it gets re-read on every new vial, not assumed from the last one. Beyond-use date — the real expiration, per the BUD guide. Storage terms — the conditions the BUD assumes. Lot number — the key that matches your certificate of analysis. Pharmacy identity — the name and address you ran through the state lookups. Directions and dose — the prescriber's instruction in milligrams, which combined with the concentration yields your units. A label missing any of these — above all an ambiguous concentration — is a call to the pharmacy before use, not a puzzle to solve at the kitchen counter.
The cross-checks that catch errors
Labels prevent errors only when read against something. Label versus prescription: drug, dose, and directions match what the prescriber ordered — telehealth's handoffs (prescriber, platform, pharmacy) occasionally drop a stitch, and you are the last inspector. Label versus last vial: the concentration comparison specifically — a refill at a different mg/mL with unchanged syringe habits is the classic serious-error setup; any change means redoing the units math from the guide before drawing. Label versus COA: lot numbers equal; the certificate's potency describes this batch. Label versus the checkout claim: total quantity versus the "month supply" sold, and the BUD versus that duration — mismatches are pre-payment questions the shelf-life guide covers. Two habits complete the system: photograph every label on arrival (a durable record for prescriber questions, error reports, or our capture file), and keep the vial in its labeled state — decanting or relabeling destroys the only authoritative document in the chain. None of this is paranoia; it's the five minutes that stands between a well-run compounded regimen and the error reports this market keeps generating, and it's the same five minutes a hospital nurse spends on far simpler medications.
Questions people ask
What's the most important thing on a compounded GLP-1 label?
The concentration (mg/mL) — every syringe calculation runs through it, it varies between pharmacies and even refills, and misreading it is the mechanism behind the serious overdose reports. Re-read it on every new vial and redo the units math whenever it changes.
What do I do if my vial's label is missing information or hard to read?
Don't use it — call the pharmacy for clarification or replacement. A label with an ambiguous drug name, concentration, BUD, or lot number can't do its safety job, and guessing at the kitchen counter is how the error reports start.
Should my new refill match my old vial exactly?
The drug and prescribed dose should; the concentration may legitimately differ — which is exactly why the label-versus-last-vial comparison exists. Any mg/mL change means recalculating your units before the first draw, and any unexpected change in drug, strength, or directions is a pharmacy call first.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.